Background and aims
Acronyms and Abbreviations:AGA (American Gastroenterological Association), CE (Chromoendoscopy), CRC (Colorectal Cancer), CD (Crohn’s Disease), CONNECT (COlorectal NEoplasia Classification to Choose the Treatment), HDWL (High-Definition White Light), HGD (High-Grade Dysplasia), IBD (Inflammatory Bowel Disease), IOA (Interobserver Agreement), JNET (Japan NBI Expert Team), LGD (Low-Grade Dysplasia), NICE (NBI International Colorectal Endoscopic), PP (Inflammatory pseudopolyps), PSC (Primary Sclerosing Cholangitis), SSL (Sessile Serrated Lesion), SEC (Serrated Epithelial Changes), SCENIC (International Surveillance for Colorectal Endoscopic Neoplasia Detection and Management in Inflammatory Bowel Disease Patients), TA (Tubular adenoma), TVA (Tubulovillous adenoma), UC (Ulcerative Colitis), WHO (World Health Organization)
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Publication stageIn Press Journal Pre-Proof
Grant Support: Mayo Clinic, Rochester, MN, Small Grant Award. “This support was made possible by the Mayo Clinic CTSA through grant number UL1 TR000135 from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH).”
The authors have no conflicts of interest related with the present manuscript. Laura H. Raffals is on the advisory board for Janssen Pharmaceuticals. James E. East has served on a clinical advisory board for Paion, on the clinical advisory board and has shared options in Satisfai Health; and reports speaker fees from Falk, Jannsen and Medtronic. Sunanda V. Kane is a consultant to Boerhinger Ingelheim, Bristol Meyers Squibb, Gilead, Janssen, Kinetix Health, InveniAI, Seres Therapeutics, TechLab, Takeda and is on the Scientific Advisory Board of PredictaMed. Edward V Loftus Jr is consultant to AbbVie, Amgen, Arena, Boehringer Ingelheim, Bristol-Myers Squibb, CALIBR, Celgene, Eli Lilly, Fresenius Kabi, Genentech, Gilead, Gossamer Bio, Iterative Scopes, Janssen, Morphic, Ono Pharma, Pfizer, Protagonist, Scipher, Sun Pharma, Surrozen, Takeda, and UCB; has received research support from AbbVie, Bristol-Myers Squibb, Celgene/Receptos, Genentech, Gilead, Gossamer Bio, Janssen, Pfizer, Takeda, Theravance, and UCB; and is a shareholder in Exact Sciences. David H. Bruining is on the advisory board for Janssen Pharmaceutical and has research support from Medtronics and Takeda. John B. Kisiel is a named inventor of Mayo Clinic intellectual property licensed to Exact Sciences and receives research support from Exact Sciences.
Daniela Guerrero Vinsard
Study concept and design, acquisition of data, obtained funding, analysis and interpretation of data, presented data in national meeting, wrote, revised, and edited the manuscript.
Study design, statistical analysis of data, co-wrote, and critically revised the manuscript.
All additional authors
Equally contributed to grading 100 images and 30 videos containing colorectal lesions. Critically reviewed and edited the manuscript for important intellectual content.
Led the study, obtained funding, co-wrote, and critically reviewed the manuscript. Study supervision.